排序方式: 共有21条查询结果,搜索用时 78 毫秒
11.
12.
13.
14.
Walid K. Abu Saleh Odeaa Al Jabbari Ashrith Guha Matthias Loebe Brian A. Bruckner 《Methodist DeBakey Cardiovascular Journal》2015,11(1):4-8
Treatment of patients with INTERMACS class I heart failure can be very challenging, and temporary long-term device support may be needed. In this article, we review the currently available temporary support devices in order to support these severely ill patients with decompensated heart failure. Strategies of using a temporary assist as a bridge to long-term device support are also discussed. 相似文献
15.
16.
Development of a Severe Mitral Valve Stenosis Secondary to the Treatment of Mitral Regurgitation with a Single MitraClip 下载免费PDF全文
17.
Basel Ramlawi Walid K. Abu Saleh Odeaa Al Jabbari Colin M. Barker Neal S. Kleiman Michael J. Reardon 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2016,43(1):75-77
Transcatheter aortic valve replacement is becoming a routine procedure to treat severe symptomatic aortic stenosis. At most transcatheter aortic valve replacement centers, transapical access is a frequent alternative for use in patients whose ileofemoral access is inadequate. Transapical access is increasingly applied to a variety of other structural heart and aortic procedures as well.There is a caveat, however. When performed in elderly patients with friable myocardium, transapical access is associated with such serious sequelae as bleeding and left ventricular apical pseudoaneurysmal formation.Here, we describe the case of a 70-year-old woman who developed a left ventricular apical pseudoaneurysm 3 weeks after transapical transcatheter aortic valve replacement. Our successful repair took a minimally invasive left lateral approach that involved peripheral cardiopulmonary bypass cannulation, Foley catheter occlusion and primary defect closure, and BioGlue reinforcement. 相似文献
18.
Walid K. Abu Saleh Odeaa Aljabbari Mahesh Ramchandani 《Methodist DeBakey Cardiovascular Journal》2015,11(3):192-194
Primary salivary type lung cancers are extremely rare intrathoracic malignancies. Mucoepidermoid tumor is one of the salivary gland tumors that originates from submucosal glands of the tracheobronchial tree. These are very slow-growing low-grade malignant tumors. Surgery is the mainstay of treatment and rarely requires adjuvant therapy. In this case report we describe a 65-year-old woman who presented with a solitary cough yet on further investigation was found to have a mucoepidermoid tumor originating from the hilum of the left lung. 相似文献
19.
Walid K. Abu Saleh Odeaa Al Jabbari Alan Lumsden Mahesh K. Ramchandani 《Methodist DeBakey Cardiovascular Journal》2015,11(4):245-246
The ability to attain high-definition imaging for preoperative planning, intraoperative execution, and postoperative evaluation is instrumental in surgical practice. Hybrid room computed tomography (CT) allows for faster, less invasive diagnostic and therapeutic options for patients. We present our diagnostic workup and therapeutic intervention with hybrid CT imaging in a 71-year-old female with a growing lung nodule after previous lobectomy for lung cancer. 相似文献
20.
Henning Kelbaek Leif Thuesen Steffen Helqvist Lene Kl?vgaard Erik J?rgensen Samir Aljabbari Kari Saunam?ki Lars R Krusell Gunnar V H Jensen Hans E B?tker Jens F Lassen Henning R Andersen Per Thayssen Anders Gall?e Anton van Weert 《Journal of the American College of Cardiology》2006,47(2):449-455
OBJECTIVES: The purpose of the SCANDSTENT study was to evaluate the use of sirolimus-eluting stents (SES) in complex coronary lesions. BACKGROUND: The use of SES improves angiographic and clinical outcomes compared with bare-metal stents (BMS) in simple coronary artery lesions, but there is limited evidence of their safety and efficacy when implanted in complex lesions. METHODS: We randomly assigned 322 patients with symptomatic complex coronary artery disease to receive either SES or BMS. The lesions were occluded (36%), bifurcational (34%), ostial (22%), or angulated (8%) in morphology. The primary end point was the difference in minimal lumen diameter six months after stent implantation. RESULTS: The patients were well matched in terms of demographic and angiographic baseline characteristics; 18% had diabetes. The reference vessel diameter was 2.86 mm in mean, and the lesion length 18.0 mm. At follow-up, patients who received SES had a minimal lumen diameter of 2.48 mm compared with 1.65 mm in those who received BMS (p < 0.001), a diameter stenosis of 19.3% versus 43.8% (p < 0.001), and 2.0% versus 31.9% developed restenosis (p < 0.001). The rate of major adverse cardiac events was 4.3% with SES versus 29.3% with BMS (p < 0.001), and stent thrombosis was observed in 0.6% in the SES group versus 3.1% in the BMS group (p = 0.15). CONCLUSIONS: The use of SES markedly reduced restenosis and the occurrence of major adverse cardiac events in patients with complex coronary artery lesions without increasing the risk of stent thrombosis. 相似文献